Brannon Perilloux
Adolescent Medicine · Baton Rouge, LANPI 1578670063
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 29.5% of the total. Reporting peaked in 2019 at $853 and has fallen 97.8% since, to $19 in 2025. Among adolescent medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$419
- Tris Pharma Inc$350
- Neos Therapeutics, LP$259
- Takeda Pharmaceuticals U.S.A., Inc.$146
- Merck$55
- Adlon Therapeutics L.p.$42
- plus $149 from 8 others
Across 75 payments — averaging $3347.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novavax Inc$168K
- AbbVie$40K
- Janssen Research & Development, LLC$16K
- GSK$10K
- AstraZeneca$9K
- Pfizer$7K
- plus $2K from 1 others
What the payments were for
- Food & beverage$1,419100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 4 | $419 |
| Tris Pharma Inc | 21 | $350 |
| Neos Therapeutics, LP | 15 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| Merck | 3 | $55 |
| Adlon Therapeutics L.p. | 3 | $42 |
| Kaleo, Inc. | 2 | $30 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| GSK | 1 | $18 |
| Sobi, Inc | 1 | $15 |
| Corium, LLC | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Pfizer | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,419 in reported general payments places this provider in the 90th percentile of 34 adolescent medicine providers in Louisiana.
Other adolescent medicine in Baton Rouge
- Robert DrummBaton Rouge$1K
- Rodger ElofsonBaton Rouge$949
- Dana FakouriBaton Rouge$656
- Karen SimpsonBaton Rouge$139
- Jennifer HoganBaton Rouge$133
- Melvin MurrillBaton Rouge$95
- Timothy HonigmanBaton Rouge$30
- Alan YagerMetairie$6K
- Leslie BerHouma$4K
- Nicole Kerley-McguireHouma$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.